Sign in
4

Changes in Ownership

Immunocore Holdings plc Filed Acc 0001415889-25-013622

Options or other derivatives

  • Director acquired 26,198 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Bell John Irving Director 2025-05-15 Grant or award · Share Option (Right to Buy) +26,198 26,198 D
Loading xslF345X05/form4-05192025_040504.xml…